Pressure BioSciences (OTCQB: PBIO) (“PBI”) founder, president and CEO Ric Schumacher was a guest on a recent episode of “Emerging Technology Insider,” which regularly releases video conversations with management of technology companies with business or financial objectives. During the interview, Schumacher focused on the company’s recently announced food industry consortium partnership with The Ohio State University and the impact it may have on the food industry. The agreement between PBI and the College of Food, Agricultural, and Environmental Sciences at Ohio State calls for PBI to install several models of its patented Ultra Shear Technology(TM) (“UST”) platform in the state-of-the-art Ohio State food pilot plant. The plant provides careful temperature and pressure control. During the interview, Schumacher noted that members of the consortium will have first access to the UST test systems and food applications developed in the pilot plant, including licensing opportunities to leverage new applications of PBI’s UST platform and other consortium-developed IP. Schumacher also noted several primary goals and benefits for food companies that join the consortium, which will be comprised of many global, well-known, leading food and beverage companies from around the world. For instance, UST, which is PBI’s proprietary method for homogenizing immiscible liquids, could potentially result in the availability of food that offers greater safety, improved absorption, better taste/smell/texture, longer room temperature shelf life and more “clean labels” (reduced or no unwanted chemical additives). The consortium will focus on advancing the commercialization of PBI’s UST platform through the quality enhancement of beverages and liquid foods, including many dairy products, condiments and sauces. The group will also focus on identifying methods to reduce costs of processing, shipping, distribution, storage and spoilage through extended room temperature stability, without compromising quality or sensory experience of the products.
To view the full press release, visit https://ibn.fm/BZEJ3
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is on the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
